Ivax

Dr. Frost had been chairman and chief executive of Ivax since 1987, and the other insider buyer, Opko Vice Chairman and Chief Technical Officer Jane Hsiao worked with him there.

Opko CEO Frost Accelerates Share Purchases Kathy Shwiff 2011

Quarterly earnings excluded a $1.40 per-share charge related to the January acquisition of Ivax.

Teva Could See Upside On Generic Zocor Bid 2006

Forest Labs sued Ivax, which was acquired by Teva Pharmaceutical Industries this year, when it applied to make a generic version of Lexapro.

Oil's New High Sinks Stocks 2006

The federal civil trial is being held in Delaware District Court; Ivax, a unit of Teva, and India's Cipla are challenging a patent held by Forest for its bestselling depression drug.

Forest Seen With More Than 75% Chance Of Lexapro Win 2006

Teva Pharmaceutical Industries, which completed the acquisition of Ivax in January, is one of Forman's favorites.

Six Picks In Generic Drugs 2006

The Morgan Stanley analyst said after Ivax filed the initial lawsuit in late 2003, they saw Forest's chances of winning at about 75%.

Forest Seen With More Than 75% Chance Of Lexapro Win 2006

Quarterly earnings excluded a $1.0 billion charge related to the January acquisition of Ivax.

Biotechs Battered As FDA Action Heats Up 2006

The analyst said Forest's next catalyst is a possible patent-dispute settlement with generic challenger Ivax over the depression treatment Lexapro.

Lexapro Settlement Would Boost Forest Labs As Much As 10% 2006

TEVA, the world's biggest maker of generic drugs, founded Ivax Corp., a maker of generic drugs that Teva bought for $7.6 billion in 2006.

unknown title 2011

Before Ivax, Dr. Frost headed a much smaller pharmaceutical company as chairman and CEO of Key Pharmaceuticals, which also ended up being bought out, in 1986.

Forbes.com: News Gene Marcial 2011